Immune cells that are empowered by gene-engineering to seek and destroy cancer cells (engineered T cell therapy) constitute a transformative novel treatment that has the potential to cure cancer. Multiple new versions of this therapy are being developed for distinct...
Increasing European ICU Performance Capacity. The vision and key objective of ICU4Covid is to deliver intensive care medicine fit for the fight against COVID-19 to the EU citizen and the health workforce rapidly and at scale by clinically validating and deploying the...
The project ImmUniverse has been formed as a European transdisciplinary consortium to tackle these unmet needs and to understand the role of the crosstalk between tissue microenvironment and immune cells in disease progression and response to...
The vision of Immune Safety Avatar (imSAVAR) is to develop a platform for integrated nonclinical assessments of immunomodulatory therapy safety and efficacy. Existing nonclinical models do not adequately represent the complexity of the immune system and its...
ITTM was certified in 2019 as one of the very first SMEs by the IMI EHDEN and since the is part of the EHDEN SME marketplace: https://www.ehden.eu/business-directory/ITTM offers services aroundOHDSI Software and Tools: Installation of the analytical infrastructure,...
